Below you find a list of LEO Pharma's most recent press releases. The press releases are only intended for use by journalists.
13-08-2019 LEO Pharma A/S acquires rights to develop and market brodalumab for moderate-to-severe psoriasis outside of Europe
10-05-2019 LEO Pharma Strengthens US footprint and Global Development Team with appointment of Vice Presidents for Global Regulatory Affairs and Global Project Management
11-04-2019 LEO Pharma and Research Project BIOMAP: Towards Personalised Medicine for Inflammatory Skin Diseases
09-04-2019 LEO Pharma and Elektrofi expand partnership to co-develop new antibodies with the aim of achieving improvements in drug delivery within dermatology
19-03-2019 LEO Pharma A/S and LTS Lohmann Therapie-Systeme AG initiate first-ever clinical trial of microarray patches for psoriasis treatment
01-03-2019 LEO Pharma showcases data in four disease areas at 2019 American Academy of Dermatology Annual Meeting in Washington, D.C.
28-01-2019 LEO Pharma further Boosts Focus on Translational Medicine with the Appointment of Thomas Hultsch as Head of Translational Medicine
09-01-2019 LEO Pharma Strengthens Focus on Translational Medicine with the Appointment of Adam B. Raff as Director and Medical Advisor
03-12-2018 LEO Pharma initiates phase 2b clinical studies of topical delgocitinib cream in adults for the treatment of both atopic dermatitis and chronic hand eczema
20-11-2018 LEO Pharma and PellePharm Announce $760 Million Collaboration to Advance Innovative Therapies for Rare Skin Diseases
23-10-2018 LEO Pharma and Zymeworks Enter into Bispecific Antibody Licensing and Research Collaboration
22-10-2018 World Psoriasis Day 2018: LEO Pharma urges people to connect with what’s under the skin of psoriasis to see the seriousness of the condition
17-09-2018 LEO Pharma and MorphoSys Expand Strategic Alliance to Develop Peptide-derived Therapeutics